Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Bacteriophage lysins and related bacteriolytic enzymes are now considered among the top antibiotic alternatives for solving the mounting resistance problem. Over the past 17 years, lysins have been widely developed against Gram-positive and recently Gram-negative pathogens, and successfully tested in a variety of animal models to demonstrate their...
Alternative Titles
Full title
Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_330edfe3654d45d0a290d0659e534506
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_330edfe3654d45d0a290d0659e534506
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v10060310
